Sep 23, 2009
Treating the Obesity Epidemic
Drugmaker Vivus saw its experimental weight-loss medication, Qnexa, pass two Phase III clinical trials C&EN reported on September 10, and the company’s share price skyrocket.
The rewards of developing a safe and effective anti-obesity medication will be in the tens of billions of dollars, according to Bloomberg. Of course, such apparent breakthroughs are going to hit the headlines, big time. After all, who wants to reduce calorie intake and increase exercise levels when popping …
UPDATED: Is it possible that obesity, like the common cold is infectious? You’d think so if you believed research that’s been carried out over the last decade and hits the tabloid headlines again this week.
We all know we’re all getting fatter, don’t we? Obesity has become the latest plague of the developed world. And, body mass index has become the vital statistic your GP is most interested.
Sciencebase FAQ
Contact me
